ATI RN
Principles of Pharmacology Quizlet Questions
Question 1 of 5
The nurse is developing goals in collaboration with a patient. Which is the best goal statement?
Correct Answer: C
Rationale: The correct answer is C because it is specific, measurable, achievable, relevant, and time-bound (SMART). It clearly states the goal of independently self-administering the prescribed dose of albuterol by the end of the second teaching session. This goal is clear and concrete, allowing for easy evaluation of progress. Choice A is not the best because it lacks specificity regarding independence. Choice B lacks the clarity of when the goal should be achieved. Choice D is irrelevant to the specific task of self-administering albuterol. In summary, choice C is the best goal statement as it meets the criteria of a well-defined and achievable goal in collaboration with the patient.
Question 2 of 5
The clinical research nurse knows that only a small proportion of drugs survive the research and development process. An appreciation of the process and associated costs grows when the nurse is aware that approximately one in how many potential drugs is approved by the US Food and Drug Administration?
Correct Answer: B
Rationale: The correct answer is B: 1000. The approval rate by the FDA is around 1 in 1000 potential drugs. This means that out of a large number of drug candidates, only a very small percentage actually make it through the rigorous research and development process to receive FDA approval. Choice A (100) is too low and would imply a much higher approval rate. Choices C (10,000) and D (100,000) are too high, suggesting an even lower approval rate, which is not the case based on industry standards. Thus, the most accurate representation of the approval rate is 1 in 1000, making option B the correct answer.
Question 3 of 5
The nurse researcher reviews the proposed informed consent form for a future clinical trial. The nurse expects to find which in the document? (Select all that apply.)
Correct Answer: A
Rationale: The correct answer is A because the informed consent form should include a clear description of the benefits and risks associated with participating in the clinical trial. This information is crucial for participants to make an informed decision about their involvement. Option B is incorrect as it focuses on specific details rather than general benefits and risks. Option C is incorrect since outcomes are typically discussed after the trial, not in the initial informed consent form. Option D is incorrect as compensation details should not be included in the informed consent form to prevent coercion or inducement.
Question 4 of 5
The nurse is reviewing the drug-approval process in the United States and learns that the Food and Drug Administration Modernization Act of 1997 contains which provisions? (Select all that apply.)
Correct Answer: A
Rationale: The correct answer is A: Review of new drugs is accelerated. The FDA Modernization Act of 1997 aimed to expedite the drug-approval process by streamlining regulations and providing more efficient pathways for approval. This provision allowed for faster review of new drugs to get them to market more quickly. Choice B is incorrect because off-label use of drugs is not specifically addressed in the FDA Modernization Act of 1997. Choice C is incorrect because the privacy of individually identifiable health information is more related to HIPAA regulations rather than the FDA Modernization Act. Choice D is incorrect because the act does not require drug companies to offer advanced notice of plans to discontinue drugs.
Question 5 of 5
The nurse will question the health care provider if a drug with a half-life ( t ½) of more than 24 hours is ordered to be given more than how often?
Correct Answer: A
Rationale: The correct answer is A: Once daily. A drug with a half-life of more than 24 hours takes longer to be eliminated from the body. To maintain therapeutic levels and avoid accumulation, the drug should be given less frequently than its half-life. Giving it once daily ensures a consistent level in the body. Choices B, C, and D are incorrect because they are less frequent dosing intervals than once daily, which could lead to subtherapeutic levels or accumulation of the drug.